SecBot SecBot
Home › SEC Filings › Current Report (8-K)

Current Report (8-K)

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
CNBX8-Kbearish5/10CNBX Pharmaceuticals dismissed its auditor, Elkana Amitai CPA, and hired Vilki & Co., a firm based in Gujarat, India, efOct 1, 2026
DPLS8-Kneutral4/10DarkPulse announced it signed an exclusive U.S. patent license agreement with the U.S. Air Force Research Laboratory forOct 1, 2026
MATW8-Kneutral3/10Matthews International announced that two long-tenured directors, Katherine E. Dietze and Morgan K. O'Brien, will not stOct 1, 2026
SHBI8-Kneutral2/10Shore Bancshares adopted a new Deferred Compensation Plan for Non-employee Directors effective December 31, 2026, and siOct 1, 2026
AMOD8-Kbearish7/10Alpha Modus Holdings closed the previously announced PIPE Transaction, issuing 51,621,560 shares and warrants for an addOct 1, 2026
MOJO8-Kbullish6/10EQUATOR Beverage Co reported a strong Q3 2026 earnings turnaround, swinging to net income of $156,777 from a net loss ofOct 1, 2026
OSBC8-Kneutral2/10Old Second Bancorp filed an 8-K solely to announce the upcoming release of Q3 2026 financial results after market close Oct 1, 2026
WTS8-Kneutral3/10Watts Water Technologies announced the planned retirement of General Counsel, Chief Sustainability Officer, Chief CompliOct 1, 2026
KITT8-Kneutral4/10Nauticus Robotics obtained a waiver from a Series A preferred stock holder, extending the deadline for outstanding prefeOct 1, 2026
PLMK8-Kbullish6/10Plum Acquisition Corp. IV (PLMK) announced that its target, Controlled Thermal Resources (CTR), has signed agreements wiOct 1, 2026
GANX8-Kbullish6/10Gain Therapeutics announced long-term open-label extension data from its Phase 1b study of rexaceract in Parkinson's disOct 1, 2026
BCDA8-Kneutral4/10BioCardia filed a revised De Novo pre-submission with the FDA CDRH for its Helix Catheter, a device for therapeutic and Oct 1, 2026
APUS8-Kneutral2/10Apimeds Pharmaceuticals US, Inc. disclosed the resignation of Interim CFO Erick Frim effective September 29, 2026, and tOct 1, 2026
WAMFF8-Kneutral3/10Alaska Silver Corp. announced the transition of Aaron Schutt to CEO, effective October 1, 2026, succeeding co-founder KiOct 1, 2026
LDOS8-Kneutral2/10Leidos Holdings, Inc. appointed Jeffery S. McElfresh, AT&T's COO, to its board of directors effective October 1, 2026, eOct 1, 2026
SINT8-Kbullish6/10SINTX reported preliminary Q3 2026 revenue of $2.2M, exceeding its guidance range of $0.9M-$1.1M and representing roughlOct 1, 2026
ROP8-Kneutral2/10Roper Technologies appointed Abhijit Dubey, CEO and Chief AI Officer of NTT DATA, Inc., to its Board of Directors effectOct 1, 2026
DARE8-Kneutral2/10Dare Bioscience filed an 8-K on October 1, 2026, to furnish a corporate investor presentation (Exhibit 99.1) under Item Oct 1, 2026
NVCR8-Kbullish6/10NovoCure announced that Japan's MHLW approved Optune Pax for unresectable locally advanced pancreatic cancer, based on tOct 1, 2026
CHH8-Kneutral2/10Choice Hotels announced that Chief Human Resources Officer Patrick Cimerola will transition from his role at the end of Oct 1, 2026
LRHC8-Kbearish7/10La Rosa Holdings Corp. entered into a complex asset contribution and securities purchase agreement to acquire graphics pOct 1, 2026
FCCO8-Kneutral2/10First Community Corporation announced the appointment of Terrance Ford and Shell K. Berry to its board of directors, effOct 1, 2026
USBC8-Kneutral4/10USBC entered into an unsecured promissory note with Goldeneye 1995 LLC, an entity controlled by its Chairman and CEO RobOct 1, 2026
CAPS8-Kneutral4/10Capstone Holding Corp. released preliminary July-August 2026 operating results showing 7.6% organic revenue growth to ~$Oct 1, 2026
VHC8-Kbearish5/10VirnetX entered into an at-the-market (ATM) offering agreement with Titan Partners Securities to sell up to $19,135,717 Oct 1, 2026
AMCI8-Kneutral2/10AMC Robotics appointed Dr. Ang Li as Chief Technology Officer on October 1, 2026. Dr. Li, an AI and edge computing experOct 1, 2026
VIR8-Kneutral2/10Vir Biotechnology appointed Aziz Sawaf as Executive Vice President and CFO, effective October 5, 2026, replacing interimOct 1, 2026
CION8-Kneutral2/10CION Investment Corp filed an 8-K on October 1, 2026, solely to announce the scheduling of its Q3 2026 earnings release Oct 1, 2026
AASP8-Kneutral3/10Agassi Sports Entertainment Corp. announced the formation of Let's Play, LLC, a wholly-owned subsidiary focused on buildOct 1, 2026
AVX8-Kneutral3/10AVAX One Technology disclosed its September 2026 share repurchase activity under its existing $40 million buyback prograOct 1, 2026
« Previous Page 180 of 334 Next »